BIO honors Representative Kind as Legislator of the Year.
Share:
Press Release Summary:
Representative Ron Kind (D-WI) was presented with Legislator of the Year Award during BIO's Legislative Day Fly-In. Congressman Kind is a supporter of biotechnology and has demonstrated dedication through leadership on national policy and work on House Ways and Means Committee. "By presenting this award, BIO recognizes Congressman Kind's diligent support of legislation that would create a pathway for the development and approval of biologic medicines," said BIO President and CEO, Jim Greenwood.
Original Press Release:
Representative Kind Honored as BIO Legislator of the Year
WASHINGTON, D.C. (Friday, April 03, 2009) - The Biotechnology Industry Organization (BIO) announced today its selection of Representative Ron Kind (D - WI) as a Legislator of the Year for 2008-2009. The award was presented this week as part of BIO's Legislative Day Fly-In.
"Congressman Kind has distinguished himself as a strong leader for policy that will help our nation's biotechnology sector thrive and benefit people everywhere. By presenting this award, BIO recognizes Congressman Kind's diligent support of legislation that would create a pathway for the development and approval of biologic medicines," said BIO President and CEO Jim Greenwood. "We also thank him for his efforts to ensure that comparative effectiveness research is done in a way that will determine the best clinical outcome."
"Congressman Kind is an ardent supporter of biotechnology and has demonstrated his dedication through leadership on national policy and the important work he has done on the House Ways & Means Committee. He understands the benefits the industry provides in the form of economic stability and more high-paying jobs for the state of Wisconsin," said Dr. Laura Strong, President of Quintessence Biosciences, located in Madison, WI. "On behalf of Wisconsin's life sciences industry, we salute Congressman Kind's efforts. He is a true friend of the bioscience community and the patients that we serve."
During the BIO Legislative Day Fly-In, more than 250 biotechnology industry representatives from 36 states, including Wisconsin, participated in hundreds of meetings with key Members of the House and Senate. Participants discussed issues critical to the biotechnology industry, including biosimilars, Food and Drug Administration appropriations, biofuels, and patent reform.
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
